Anusha Kalbasi

Title(s)Assistant Professor-in-Residence, Radiation Oncology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Assistant Professor-in-Residence, Surgery


    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma. Cancer Med. 2022 Mar 20. Chantharasamee J, Wong K, Potivongsajarn P, Qorbani A, Motamed N, Brackert S, Cohen J, Chmielowski B, Kalbasi A, Rao J, Nelson S, Singh A. PMID: 35307963.
      View in: PubMed   Mentions:
    2. Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy. J Immunother Cancer. 2022 03; 10(3). Campbell KM, Thaker M, Medina E, Kalbasi A, Singh A, Ribas A, Nowicki TS. PMID: 35264439; PMCID: PMC8915285.
      View in: PubMed   Mentions:
    3. Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy. J Immunother Cancer. 2022 02; 10(2). Weidhaas J, Marco N, Scheffler AW, Kalbasi A, Wilenius K, Rietdorf E, Gill J, Heilig M, Desler C, Chin RK, Kaprealian T, McCloskey S, Raldow A, Raja NP, Kesari S, Carrillo J, Drakaki A, Scholz M, Telesca D. PMID: 35115362; PMCID: PMC8804679.
      View in: PubMed   Mentions:
    4. Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma. Sarcoma. 2021; 2021:3735874. Valle LF, Bernthal N, Eilber FC, Shabason JE, Bedi M, Kalbasi A. PMID: 34720663; PMCID: PMC8556117.
      View in: PubMed   Mentions:
    5. Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation. Med Phys. 2021 Jun; 48(6):3262-3372. Gao Y, Ghodrati V, Kalbasi A, Fu J, Ruan D, Cao M, Wang C, Eilber FC, Bernthal N, Bukata S, Dry SM, Nelson SD, Kamrava M, Lewis J, Low DA, Steinberg M, Hu P, Yang Y. PMID: 33908045.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Radiotherapy Remains Underused in the Treatment of Soft-Tissue Sarcomas: Disparities in Practice Patterns in the United States. J Natl Compr Canc Netw. 2021 02 08; 1-12. Reddy VK, Jain V, Venigalla S, Levin WP, Wilson RJ, Weber KL, Kalbasi A, Sebro RA, Shabason JE. PMID: 33556919.
      View in: PubMed   Mentions:    Fields:    
    7. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. Cancer Discov. 2021 05; 11(5):1212-1227. Li J, Duran MA, Dhanota N, Chatila WK, Bettigole SE, Kwon J, Sriram RK, Humphries MP, Salto-Tellez M, James JA, Hanna MG, Melms JC, Vallabhaneni S, Litchfield K, Usaite I, Biswas D, Bareja R, Li HW, Martin ML, Dorsaint P, Cavallo JA, Li P, Pauli C, Gottesdiener L, DiPardo BJ, Hollmann TJ, Merghoub T, Wen HY, Reis-Filho JS, Riaz N, Su SM, Kalbasi A, Vasan N, Powell SN, Wolchok JD, Elemento O, Swanton C, Shoushtari AN, Parkes EE, Izar B, Bakhoum SF. PMID: 33372007; PMCID: PMC8102348.
      View in: PubMed   Mentions: 4     Fields:    
    8. Comparison and evaluation of distortion correction techniques on an MR-guided radiotherapy system. Med Phys. 2021 Feb; 48(2):691-702. Gao Y, Yoon S, Savjani R, Pham J, Kalbasi A, Raldow A, Low DA, Hu P, Yang Y. PMID: 33280128.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. Cancer Cell. 2021 Jan 11; 39(1):122. Grasso CS, Tsoi J, Onyshchenko M, Abril-Rodriguez G, Ross-Macdonald P, Wind-Rotolo M, Champhekar A, Medina E, Torrejon DY, Shin DS, Tran P, Kim YJ, Puig-Saus C, Campbell K, Vega-Crespo A, Quist M, Martignier C, Luke JJ, Wolchok JD, Johnson DB, Chmielowski B, Hodi FS, Bhatia S, Sharfman W, Urba WJ, Slingluff CL, Diab A, Haanen JBAG, Algarra SM, Pardoll DM, Anagnostou V, Topalian SL, Velculescu VE, Speiser DE, Kalbasi A, Ribas A. PMID: 33306984; PMCID: PMC7885306.
      View in: PubMed   Mentions: 2     Fields:    
    10. Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Sci Transl Med. 2020 10 14; 12(565). Kalbasi A, Tariveranmoshabad M, Hakimi K, Kremer S, Campbell KM, Funes JM, Vega-Crespo A, Parisi G, Champekar A, Nguyen C, Torrejon D, Shin D, Zaretsky JM, Damoiseaux RD, Speiser DE, Lopez-Casas PP, Quintero M, Ribas A. PMID: 33055240; PMCID: PMC8053376.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    11. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. Cancer Cell. 2020 10 12; 38(4):500-515.e3. Grasso CS, Tsoi J, Onyshchenko M, Abril-Rodriguez G, Ross-Macdonald P, Wind-Rotolo M, Champhekar A, Medina E, Torrejon DY, Shin DS, Tran P, Kim YJ, Puig-Saus C, Campbell K, Vega-Crespo A, Quist M, Martignier C, Luke JJ, Wolchok JD, Johnson DB, Chmielowski B, Hodi FS, Bhatia S, Sharfman W, Urba WJ, Slingluff CL, Diab A, Haanen JBAG, Algarra SM, Pardoll DM, Anagnostou V, Topalian SL, Velculescu VE, Speiser DE, Kalbasi A, Ribas A. PMID: 32916126; PMCID: PMC7872287.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    12. Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs. Phys Med Biol. 2020 08 27; 65(17):175006. Gao Y, Kalbasi A, Hsu W, Ruan D, Fu J, Shao J, Cao M, Wang C, Eilber FC, Bernthal N, Bukata S, Dry SM, Nelson SD, Kamrava M, Lewis J, Low DA, Steinberg M, Hu P, Yang Y. PMID: 32554891.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma. Cancers (Basel). 2020 Aug 24; 12(9). Graham DS, van Dams R, Jackson NJ, Onyshchenko M, Eckardt MA, DiPardo BJ, Nelson SD, Chmielowski B, Shabason JE, Singh AS, Eilber FC, Kalbasi A. PMID: 32846908; PMCID: PMC7564235.
      View in: PubMed   Mentions:
    14. Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis. J Natl Compr Canc Netw. 2020 08; 18(8):1055-1065. Graham DS, Onyshchenko M, Eckardt MA, DiPardo BJ, Venigalla S, Nelson SD, Chmielowski B, Singh AS, Shabason JE, Eilber FC, Kalbasi A. PMID: 32755981.
      View in: PubMed   Mentions: 1     Fields:    
    15. Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach. bioRxiv. 2020 Jun 29. Campbell KM, Steiner G, Wells DK, Ribas A, Kalbasi A. PMID: 32511325; PMCID: PMC7239055.
      View in: PubMed   Mentions:
    16. Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy. Adv Radiat Oncol. 2020 Nov-Dec; 5(6):1334-1341. Qi XS, Chu FI, Zhang Z, Chin RK, Raldow A, Kishan AU, Lee P, Chang A, Kalbasi A, Kamrava M, Steinberg ML, Low DA. PMID: 33305096; PMCID: PMC7718556.
      View in: PubMed   Mentions:
    17. Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade. Cancer Discov. 2020 08; 10(8):1140-1157. Torrejon DY, Abril-Rodriguez G, Champhekar AS, Tsoi J, Campbell KM, Kalbasi A, Parisi G, Zaretsky JM, Garcia-Diaz A, Puig-Saus C, Cheung-Lau G, Wohlwender T, Krystofinski P, Vega-Crespo A, Lee CM, Mascaro P, Grasso CS, Berent-Maoz B, Comin-Anduix B, Hu-Lieskovan S, Ribas A. PMID: 32467343; PMCID: PMC7416458.
      View in: PubMed   Mentions: 13     Fields:    
    18. How Technology Is Improving the Multidisciplinary Care of Sarcoma. Am Soc Clin Oncol Educ Book. 2020 May; 40:445-462. Schaefer IM, Hong K, Kalbasi A. PMID: 32421448; PMCID: PMC8009691.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Tumor Size Matters-Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy. Cancers (Basel). 2020 Mar 18; 12(3). Nesseler JP, Lee MH, Nguyen C, Kalbasi A, Sayre JW, Romero T, Nickers P, McBride WH, Schaue D. PMID: 32197352; PMCID: PMC7140082.
      View in: PubMed   Mentions: 5  
    20. A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma. Clin Cancer Res. 2020 04 15; 26(8):1829-1836. Kalbasi A, Kamrava M, Chu FI, Telesca D, Van Dams R, Yang Y, Ruan D, Nelson SD, Dry SM, Hernandez J, Chmielowski B, Singh AS, Bukata SV, Bernthal NM, Steinberg ML, Weidhaas JB, Eilber FC. PMID: 32054730; PMCID: PMC7189949.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    21. Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy. Nat Cancer. 2020 02; 1(2):264. Abril-Rodriguez G, Torrejon DY, Liu W, Zaretsky JM, Nowicki TS, Tsoi J, Puig-Saus C, Baselga-Carretero I, Medina E, Quist MJ, Garcia AJ, Senapedis W, Baloglu E, Kalbasi A, Cheung-Lau G, Berent-Maoz B, Comin-Anduix B, Hu-Lieskovan S, Wang CY, Grasso CS, Ribas A. PMID: 35122015.
      View in: PubMed   Mentions:
    22. PAK4 inhibition improves PD-1 blockade immunotherapy. Nat Cancer. 2020; 1(1):46-58. Abril-Rodriguez G, Torrejon DY, Liu W, Zaretsky JM, Nowicki TS, Tsoi J, Puig-Saus C, Baselga-Carretero I, Medina E, Quist MJ, Garcia AJ, Senapedis W, Baloglu E, Kalbasi A, Cheung-Lau G, Berent-Maoz B, Comin-Anduix B, Hu-Lieskovan S, Wang CY, Grasso CS, Ribas A. PMID: 34368780; PMCID: PMC8340852.
      View in: PubMed   Mentions: 1  
    23. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center. Am J Clin Oncol. 2019 10; 42(10):739-743. Graham DS, Russell TA, Eckardt MA, Motamedi K, Seeger LL, Singh AS, Bernthal NM, Kalbasi A, Dry SM, Nelson SD, Elashoff D, Levine BD, Eilber FC. PMID: 31436746.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol. 2020 01; 20(1):25-39. Kalbasi A, Ribas A. PMID: 31570880; PMCID: PMC8499690.
      View in: PubMed   Mentions: 148     Fields:    Translation:HumansAnimalsCells
    25. Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy. Nucl Med Commun. 2019 Jun; 40(6):618-625. Rice SR, Saboury B, Houshmand S, Salavati A, Kalbasi A, Goodman CR, Werner TJ, Vujaskovic Z, Simone CB, Alavi A. PMID: 31095527.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    26. Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors. Am J Clin Oncol. 2019 05; 42(5):426-431. Shurell-Linehan E, DiPardo BJ, Elliott IA, Graham DS, Eckardt MA, Dry SM, Nelson SD, Singh AS, Kalbasi A, Federman N, Bernthal NM, Eilber FC. PMID: 30913092.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Interleukin 32 expression in human melanoma. J Transl Med. 2019 04 05; 17(1):113. Paz H, Tsoi J, Kalbasi A, Grasso CS, McBride WH, Schaue D, Butterfield LH, Maurer DM, Ribas A, Graeber TG, Economou JS. PMID: 30953519; PMCID: PMC6449995.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    28. A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab. Clin Cancer Res. 2019 04 01; 25(7):2096-2108. Nowicki TS, Berent-Maoz B, Cheung-Lau G, Huang RR, Wang X, Tsoi J, Kaplan-Lefko P, Cabrera P, Tran J, Pang J, Macabali M, Garcilazo IP, Carretero IB, Kalbasi A, Cochran AJ, Grasso CS, Hu-Lieskovan S, Chmielowski B, Comin-Anduix B, Singh A, Ribas A. PMID: 30573690; PMCID: PMC6445780.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    29. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas. Am J Clin Oncol. 2018 12; 41(12):1154-1161. Pennington JD, Eilber FC, Eilber FR, Singh AS, Reed JP, Chmielowski B, Eckardt JJ, Bukata SV, Bernthal NM, Federman N, Nelson SD, Dry SM, Wang PC, Luu M, Selch MT, Steinberg ML, Kalbasi A, Kamrava M. PMID: 29664796.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study. Cancer Discov. 2018 10; 8(10):1250-1257. Ribas A, Medina T, Kummar S, Amin A, Kalbasi A, Drabick JJ, Barve M, Daniels GA, Wong DJ, Schmidt EV, Candia AF, Coffman RL, Leung ACF, Janssen RS. PMID: 30154193; PMCID: PMC6719557.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    31. Antigen Presentation Keeps Trending in Immunotherapy Resistance. Clin Cancer Res. 2018 07 15; 24(14):3239-3241. Kalbasi A, Ribas A. PMID: 29674509; PMCID: PMC6050090.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Proton craniospinal irradiation during the third trimester of pregnancy. Pract Radiat Oncol. 2018 May - Jun; 8(3):213-216. Kalbasi A, Kirk M, Teo BK, Diffenderfer E, Ding X, McDonough J, Murphy E, Hill-Kayser C. PMID: 29066161.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial. JCO Precis Oncol. 2017; 2017. Russell TA, Eckardt MA, Murakami T, Elliott IA, Kawaguchi K, Kiyuna T, Igarashi K, Li Y, Crompton JG, Graham DS, Dry SM, Bernthal N, Yanagawa J, Kalbasi A, Federman N, Chmielowski B, Singh AS, Hoffman RM, Eilber FC. PMID: 30613825; PMCID: PMC6319895.
      View in: PubMed   Mentions: 1  
    34. Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma. Transl Lung Cancer Res. 2017 Apr; 6(2):169-177. Kalbasi A, Rengan R. PMID: 28529899; PMCID: PMC5420542.
      View in: PubMed   Mentions:
    35. Functio Laesa: Cancer Inflammation and Therapeutic Resistance. J Oncol Pract. 2017 03; 13(3):173-180. Liu M, Kalbasi A, Beatty GL. PMID: 28282278; PMCID: PMC5456257.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations. Cancer Discov. 2017 02; 7(2):188-201. Shin DS, Zaretsky JM, Escuin-Ordinas H, Garcia-Diaz A, Hu-Lieskovan S, Kalbasi A, Grasso CS, Hugo W, Sandoval S, Torrejon DY, Palaskas N, Rodriguez GA, Parisi G, Azhdam A, Chmielowski B, Cherry G, Seja E, Berent-Maoz B, Shintaku IP, Le DT, Pardoll DM, Diaz LA, Tumeh PC, Graeber TG, Lo RS, Comin-Anduix B, Ribas A. PMID: 27903500; PMCID: PMC5296316.
      View in: PubMed   Mentions: 355     Fields:    Translation:HumansCells
    37. Expanding Tumor Lymphocytic Infiltration as a Prognostic Tool to Patients with NSCLC Who Are Treated with Radiotherapy? J Thorac Oncol. 2016 11; 11(11):e141-e142. Kalbasi A, Beatty GL, Berman AT. PMID: 27770976.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2017 Jan 01; 23(1):137-148. Kalbasi A, Komar C, Tooker GM, Liu M, Lee JW, Gladney WL, Ben-Josef E, Beatty GL. PMID: 27354473; PMCID: PMC5195913.
      View in: PubMed   Mentions: 74     Fields:    Translation:AnimalsCells
    39. PET-Based Thoracic Radiation Oncology. PET Clin. 2016 Jul; 11(3):319-32. Simone CB, Houshmand S, Kalbasi A, Salavati A, Alavi A. PMID: 27321035.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncol. 2015 Oct; 1(7):897-906. Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE. PMID: 26181727.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    41. 99mTc-phytate as a diagnostic probe for assessing inflammatory reaction in malignant tumors. Nucl Med Commun. 2015 Oct; 36(10):1042-8. Fernandes RS, Mota LG, Kalbasi A, Moghbel M, Werner TJ, Alavi A, Rubello D, Cardoso VN, de Barros AL. PMID: 26147941.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    42. Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer. 2014 Oct 01; 120(19):3089-96. Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, Bekelman JE. PMID: 24917426; PMCID: PMC4277873.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    43. Radiation and immunotherapy: a synergistic combination. J Clin Invest. 2013 Jul; 123(7):2756-63. Kalbasi A, June CH, Haas N, Vapiwala N. PMID: 23863633; PMCID: PMC4101987.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansAnimals
    44. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. J Transl Med. 2011 Apr 19; 9:43. Xie C, Kim HJ, Haw JG, Kalbasi A, Gardner BK, Li G, Rao J, Chia D, Liong M, Punzalan RR, Marks LS, Pantuck AJ, de la Taille A, Wang G, Mukouyama H, Zeng G. PMID: 21504557; PMCID: PMC3102624.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    45. CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893. J Immunother. 2010 Oct; 33(8):810-6. Kalbasi A, Fonsatti E, Natali PG, Altomonte M, Bertocci E, Cutaia O, Calabrò L, Chiou M, Tap W, Chmielowski B, Maio M, Ribas A. PMID: 20842056.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    46. Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein. J Immunother. 2010 Sep; 33(7):672-83. Kalbasi A, Shrimali RK, Chinnasamy D, Rosenberg SA. PMID: 20664359; PMCID: PMC6390957.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    Anusha's Networks
    Concepts (216)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California